Emergent BioSolutions (EBS) Operating Income Growth (3y) (2014 - 2026)
Emergent BioSolutions (EBS) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 273.62% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.84% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 4.63% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.70% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 54.58% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 40.87% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -63.87% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -90.87% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 120.38% |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | 27.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.47% |
| Dec 31, 2025 | 20.39% |
| Sep 30, 2025 | 54.51% |
| Jun 30, 2025 | 26.43% |
| Mar 31, 2025 | 93.38% |
| Dec 31, 2024 | -26.68% |
| Sep 30, 2024 | 51.00% |
| Jun 30, 2024 | -212.99% |
| Mar 31, 2024 | -24.42% |
| Dec 31, 2023 | -29.46% |
| Sep 30, 2023 | -81.20% |
| Jun 30, 2023 | -62.92% |
| Mar 31, 2023 | -133.46% |
| Dec 31, 2022 | -39.43% |
| Sep 30, 2022 | -38.22% |
| Jun 30, 2022 | -121.72% |
| Mar 31, 2022 | 31.07% |
| Dec 31, 2021 | 194.75% |
| Sep 30, 2021 | -60.03% |
| Jun 30, 2021 | -52.63% |